. On 3D univariate analysis, younger age and larger preoperative size minimally increased risk of tumor growth. Table 2 . On 2D univariate analysis, nodular enhancement in comparison to no enhancement increased risk of tumor growth. Table 1 . More tumors with nodular enhancement had growth compared to linear or no enhancement, and more tumors with larger preoperative size had growth compared to smaller tumors. These trends did not reach statistical significance, likely due to inadequate group sizes.
DISCUSSION

CONCLUSION
Maximal area measured on an axial scan is an efficient method that gives an excellent approximation of the tumor size and growth trends demonstrated with the more time-consuming volumetric method. The major risk factor for tumor growth after resection in our population is nodular enhancement on the baseline MRI. For patients with linear or no enhancement on the baseline scan, we recommend no further imaging until 5 years postoperatively unless the patient develops new symptoms. For patients with nodular enhancement on the baseline scan, we recommend obtaining annual MRIs starting at 2 years postoperatively and offering further treatment when MRI shows an increase in enhancement of >7mm 2 in maximal axial area or >133mm 3 in volume. 
Surveillance After Resection of Vestibular Schwannoma: Measurement Techniques and Predictors of Growth
REFERENCES INTRODUCTION MATERIALS AND METHODS
Volumetric measurement that follows tumor contours has been endorsed as the most mathematically accurate method. [5] [6] However, manual contouring can be labor-intensive and thus unlikely to be adopted for clinical use with present technology. Automated lesion contouring programs are not widely available and still require verification by a radiologist. The present study shows excellent correlation between 2D and 3D methods, suggesting that measurement of maximal area is an efficient method that still allows for accurate assessment of tumor size and growth. Prior studies typically categorize tumors as having growth based on a qualitative impression rather than based on a precisely determined measurement. Growth rates are then calculated for those tumors that have growth based on this impression. Carlson reported a 1D growth rate of 2.3mm/ yr and a 3D growth rate (volume estimated by an ellipsoid formula) of 1.14cm 3 / yr for recurrent tumors. 7 Vakilian studied patients after subtotal resection and reported a median growth rate of 0.53cm 3 /yr for all tumors, including those remaining stable in size. 6 We believe the present study is the first to define growth quantitatively rather than by the qualitative impression of the surgeon or radiologist. Using the present study's definition of growth consistently identifies a larger percentage of growing tumors compared to using previously published growth rate criteria. Since patients with no enhancement or linear enhancement demonstrate stable tumor size up through 5 years, we recommend no further imaging until 5 years postoperatively if there are no clinical indicators that would suggest that interval imaging would be appropriate. Since patients with nodular enhancement demonstrate increase in enhancement beginning at 2 years, we recommend obtaining follow-up annual MRIs beginning at 2 years postoperatively for this group. These findings agree with prior studies that have identified nodular enhancement as a risk factor for tumor growth. 8-10 
RESULTS
Vestibular schwannomas are benign slow-growing tumors of the cerebellopontine angle. 1 Management strategies include observation, stereotactic radiosurgery, and microsurgical resection. After surgical resection, clinical signs of tumor progression are not evident until there is significant regrowth that affects the cranial nerves or causes brainstem compression. 2 Postoperative surveillance relies heavily on imaging, and gadoliniumenhanced MRI is the gold standard imaging modality. [2] [3] [4] Objectives: We wished to compare different methods of measuring tumor growth after resection of vestibular schwannoma and to identify predictors of growth. Methods: Retrospective review was performed of patients who underwent vestibular schwannoma resection from September 1991-April 2012 and had ≥2 postoperative MRI scans. Tumor size in linear (1D), planar (2D), and volumetric dimensions (3D) and enhancement pattern were recorded using standard radiology workstation tools. This is the first study to define growth mathematically. Results: Eighty-eight patients were included in the study, with mean duration of followup of 3.9 years. Measurement of tumor size in 1D was found to have moderate correlation with 2D and 3D measurements (Pearson r=0.86 and r=0.84) . Excellent correlation was found between the 2D and 3D methods (r=0.98). Nodular enhancement increased risk for tumor growth (OR 6.25, p=0 .03 on 2D analysis). Tumors with nodular enhancement increase in size starting at 2 years postoperatively, whereas those with linear or no enhancement show no increase in size up through 5 years. Age and preoperative tumor size were also risk factors for growth (OR 0.9 / p=0.01 and OR 1.09 / p=0.02). Conclusion: 2D measurement is an efficient method that correlates well with the more time-consuming 3D method. The major risk factor for tumor growth is nodular enhancement on a baseline scan, a finding that warrants annual MRI beginning at 2 years postoperatively. Younger age and larger preoperative size minimally increased risk of growth. 
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